IL13 and asthma: Activation of DCs and ILCs through alarmins (KE 2) plays key roles in driving type 2 inflammatory responses in asthma by promoting downstream production of type 2 cytokines such as IL-4, IL-5, and IL-13 from the effector cells (KE 3) (Duchesne et al., 2022).